1.0KFF Health Newshttps://kffhealthnews.orgkhnlaurenohttps://kffhealthnews.org/news/author/khnlaureno/rich600338<blockquote class="wp-embedded-content" data-secret="l0yNpiVb3G"><a href="https://kffhealthnews.org/morning-breakout/pfizers-omicron-booster-better-against-new-subvariants/">Pfizer’s Omicron Booster Better Against New Subvariants</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://kffhealthnews.org/morning-breakout/pfizers-omicron-booster-better-against-new-subvariants/embed/#?secret=l0yNpiVb3G" width="600" height="338" title="“Pfizer’s Omicron Booster Better Against New Subvariants” — KFF Health News" data-secret="l0yNpiVb3G" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> News outlets cover data from Pfizer that show that its omicron-specific booster is better at tackling emerging covid subvariants than older shots are. Separately, the company's CEO Albert Bourla maintained that covid shots will remain "free" in the U.S. despite indirect costs.